Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Isolation Kit
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 30,495 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivo Anti-tumor Effects in Endometrial Cancer (2023-01-01)
Journal: Anti-Cancer Agents in Medicinal Chemistry (2023) IF: 2.8 -
miRNA-29-3p targets PTEN to regulate follicular development through the PI3K/Akt/mTOR signaling pathway (2023-10-21)
Journal: THERIOGENOLOGY (2023) IF: 2.8Products Cited: Penicillin-Streptomycin Solution, 100 × -
miR-128-3p increases the radiosensitivity in nasopharyngeal carcinoma via regulating vascular endothelial growth factor C (2023-08-16)
Journal: PATHOLOGY RESEARCH AND PRACTICE (2023) IF: 2.8Products Cited: RPMI-1640 -
Sevoflurane Postconditioning Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting SP1/ACSL4-Mediated Ferroptosis (2023-02-26)
Journal: HUMAN & EXPERIMENTAL TOXICOLOGY (2023) IF: 2.8Products Cited: HT22 Cells Complete Medium -
RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma (2023-10-12)
Journal: PATHOLOGY RESEARCH AND PRACTICE (2023) IF: 2.8Products Cited: Penicillin-Streptomycin Solution, 100× -
Formononetin Inhibits Microglial Inflammatory Response and Contributes to Spinal Cord Injury Repair by Targeting the EGFR/MAPK Pathway (2023-03-28)
Journal: IMMUNOLOGICAL INVESTIGATIONS (2023) IF: 2.8Products Cited: IL-1β/IL1F2, Human, Recombinant, IL-1β/IL1F2, Mouse, Recombinant -
Prebiotics Modulate Gut Microbiota-mediated T-cell Immunity to Enhance the Inhibitory Effect of Sintilimab in Lewis Lung Adenocarcinoma Model Mice (2023-10-01)
Journal: Anti-Cancer Agents in Medicinal Chemistry (2023) IF: 2.8Products Cited: Phosphate Buffer (PBS, 1 ×) -
Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma (2023-08-01)
Journal: Anti-Cancer Agents in Medicinal Chemistry (2023) IF: 2.8 -
Liuwei Dihuang Decoction Drug-containing Serum Attenuates Transforming Growth Factor-β1-induced Epithelial-mesenchymal Transition in HK-2 Cells by Inhibiting NF-κB/Snail Signaling Pathway (2023-03-24)
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2023) IF: 2.8Products Cited: DMEM(High glucose), Fetal Bovine Serum -
Superior Anticancer Potential of Nano-Paclitaxel Combined Bevacizumab Treatment in Ovarian Cancer (2023-07-01)
Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2023) IF: 2.8Products Cited: Fetal Bovine Serum, Annexin V-FITC/PI Apoptosis Kit, A2780 Cells Line, Enhanced Cell Counting Kit 8 (WST-8/CCK8), RPMI-1640 Medium
